Jazz Pharmaceuticals JAZZ Income Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $4.27B+4.9% | $4.07B+6.1% | $3.83B+4.8% | $3.66B+18.3% | ||
| —— | —— | —— | —— | ||
| $1.81B+30.6% | $1.39B+3.1% | $1.34B-5.2% | $1.42B-2.4% | ||
| $4.7B+40.1% | $3.35B+3.0% | $3.26B-12.6% | $3.72B+27.4% | ||
| —— | $716.63M+23.9% | $578.58M+983% | -$65.53M-138% | ||
| $248.56M-21.0% | $314.82M-5.5% | $333.11M+23.1% | $270.67M+95.8% | ||
| —— | -$17.98M+42.6% | -$31.31M— | —— | ||
| —— | $470.35M+57.9% | $297.93M+180% | -$372.78M-230% | ||
| -$277.39M-203% | -$91.43M+23.8% | -$119.91M+24.4% | -$158.65M-169% | ||
| —— | $560.12M+35.0% | $414.83M+285% | -$224.06M+32.0% | ||
| —— | $8.70+41.9% | $6.13+272% | -$3.57+34.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Jazz Pharmaceuticals's revenue?
- Jazz Pharmaceuticals (JAZZ) generated $4.4B in revenue over the trailing twelve months, up 9.2% year over year.
- Is Jazz Pharmaceuticals profitable?
- Jazz Pharmaceuticals is not currently profitable: it reported a net loss of $266.5M over the trailing twelve months, a -8.9% net margin.
- What is Jazz Pharmaceuticals's earnings per share?
- Jazz Pharmaceuticals's diluted EPS over the trailing twelve months is $-4.75.
- Where does Jazz Pharmaceuticals's income statement data come from?
- Every line is extracted from Jazz Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
